Skip to main content
NCBI home page
Indian Journal of Psychiatry logoLink to Indian Journal of Psychiatry
. 2002 Jul-Sep;44(3):253–259.

RESPONSE OF CARBAMZEPINE IN BIPOLAR DISORDER: KINDLERS VERSUS NON-KINDLERS

Subhash Chandra Das *, Subhash Chandra Gupta †, Soumya Basu ‡, Daya Ram *,*
PMCID: PMC2954396  PMID: 21206580

Abstract

Based on carbamazepine′s hypothesized ability to stabilize temporal lobe seizures and behavioral disorders and its ability to inhibit limbic system excitability in models such as kindling, we undertook this study with the aims of finding out the response of carbamazepine in kindler and non kindler groups and to see the relationship of socio-demographic and clinical variables in kindler and non-kindler bipolar mood disorder with response to carbamazepine. Simple random sampling was done and patients (over a period of one and a half year) between 18-50 years who had a diagnosis of Bipolar Affective Disorder, current episode mania as per lCD-10 and who had history of at least three manic or depressive episode in the past were taken. The total sample was divided into two groups i. e. kindler and non-kindlers. Kindlers were defined as patients with 3 or more affective episodes in less than equal to 1 year apart. Non-kindlers were defined as patients with at least 3 episodes in the past with inter episodic period of more than 1 year. All the patients included in this study were followed up for 6 months and were given carbamazepine in adequate dosages. Fifty -five patients completed the 6 months follow up. Results showed that there was no significant difference between the two groups based on sex, past history of substance intake, type of mood (irritable versus elated), number of relapses during the follow-up and improvement on carbamazepine. Our study does not support the kindling hypothesis.

Keywords: Carbamazepine, kindlers, non-kindlers

Full Text

The Full Text of this article is available as a PDF (288.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambelas A. Psychologically stressful events in the precipitation of manic episodes. Br J Psychiatry. 1979 Jul;135:15–21. doi: 10.1192/bjp.135.1.15. [DOI] [PubMed] [Google Scholar]
  2. Bauer M. S., Calabrese J., Dunner D. L., Post R., Whybrow P. C., Gyulai L., Tay L. K., Younkin S. R., Bynum D., Lavori P. Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry. 1994 Apr;151(4):506–515. doi: 10.1176/ajp.151.4.506. [DOI] [PubMed] [Google Scholar]
  3. Cutler N. R., Post R. M. Life course of illness in untreated manic-depressive patients. Compr Psychiatry. 1982 Mar-Apr;23(2):101–115. doi: 10.1016/0010-440x(82)90055-4. [DOI] [PubMed] [Google Scholar]
  4. Dunner D. L., Fieve R. R. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry. 1974 Feb;30(2):229–233. doi: 10.1001/archpsyc.1974.01760080077013. [DOI] [PubMed] [Google Scholar]
  5. Dunner D. L., Patrick V., Fieve R. R. Rapid cycling manic depressive patients. Compr Psychiatry. 1977 Nov-Dec;18(6):561–566. doi: 10.1016/s0010-440x(97)90006-7. [DOI] [PubMed] [Google Scholar]
  6. Gitlin M. J., Swendsen J., Heller T. L., Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995 Nov;152(11):1635–1640. doi: 10.1176/ajp.152.11.1635. [DOI] [PubMed] [Google Scholar]
  7. Goldberg J. F., Harrow M., Grossman L. S. Recurrent affective syndromes in bipolar and unipolar mood disorders at follow-up. Br J Psychiatry. 1995 Mar;166(3):382–385. doi: 10.1192/bjp.166.3.382. [DOI] [PubMed] [Google Scholar]
  8. Goldberg J. F., Harrow M. Kindling in bipolar disorders: a longitudinal follow-up study. Biol Psychiatry. 1994 Jan 1;35(1):70–72. doi: 10.1016/0006-3223(94)91169-x. [DOI] [PubMed] [Google Scholar]
  9. Greil W., Kleindienst N., Erazo N., Müller-Oerlinghausen B. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol. 1998 Dec;18(6):455–460. doi: 10.1097/00004714-199812000-00007. [DOI] [PubMed] [Google Scholar]
  10. Kessing L. V., Andersen P. K., Mortensen P. B., Bolwig T. G. Recurrence in affective disorder. I. Case register study. Br J Psychiatry. 1998 Jan;172:23–28. doi: 10.1192/bjp.172.1.23. [DOI] [PubMed] [Google Scholar]
  11. Khanna R., Gupta N., Shanker S. Course of bipolar disorder in eastern India. J Affect Disord. 1992 Jan;24(1):35–41. doi: 10.1016/0165-0327(92)90058-e. [DOI] [PubMed] [Google Scholar]
  12. Maj M., Pirozzi R., Magliano L. Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors. Am J Psychiatry. 1995 Dec;152(12):1810–1811. doi: 10.1176/ajp.152.12.1810. [DOI] [PubMed] [Google Scholar]
  13. Placidi G. F., Lenzi A., Lazzerini F., Cassano G. B., Akiskal H. S. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry. 1986 Oct;47(10):490–494. [PubMed] [Google Scholar]
  14. Post R. M., Rubinow D. R., Ballenger J. C. Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry. 1986 Aug;149:191–201. doi: 10.1192/bjp.149.2.191. [DOI] [PubMed] [Google Scholar]
  15. Post R. M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992 Aug;149(8):999–1010. doi: 10.1176/ajp.149.8.999. [DOI] [PubMed] [Google Scholar]
  16. Post R. M., Uhde T. W., Ballenger J. C., Squillace K. M. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry. 1983 Dec;140(12):1602–1604. doi: 10.1176/ajp.140.12.1602. [DOI] [PubMed] [Google Scholar]
  17. Post R. M., Uhde T. W., Putnam F. W., Ballenger J. C., Berrettini W. H. Kindling and carbamazepine in affective illness. J Nerv Ment Dis. 1982 Dec;170(12):717–731. doi: 10.1097/00005053-198212000-00002. [DOI] [PubMed] [Google Scholar]
  18. Post R. M., Weiss S. R. Ziskind-Somerfeld Research Award 1992. Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. Biol Psychiatry. 1992 Sep 15;32(6):469–484. doi: 10.1016/0006-3223(92)90216-m. [DOI] [PubMed] [Google Scholar]
  19. Tohen M., Waternaux C. M., Tsuang M. T. Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry. 1990 Dec;47(12):1106–1111. doi: 10.1001/archpsyc.1990.01810240026005. [DOI] [PubMed] [Google Scholar]
  20. Turvey C. L., Coryell W. H., Solomon D. A., Leon A. C., Endicott J., Keller M. B., Akiskal H. Long-term prognosis of bipolar I disorder. Acta Psychiatr Scand. 1999 Feb;99(2):110–119. doi: 10.1111/j.1600-0447.1999.tb07208.x. [DOI] [PubMed] [Google Scholar]
  21. Winokur G., Coryell W., Keller M., Endicott J., Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry. 1993 Jun;50(6):457–465. doi: 10.1001/archpsyc.1993.01820180059006. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Psychiatry are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES